NDC 76162-900

Cold Sore Fever Blister Treatment

Docosanol

Cold Sore Fever Blister Treatment is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by Topco Associates. The primary component is Docosanol.

Product ID76162-900_db7e591e-9cbf-49c9-acbd-92110b979388
NDC76162-900
Product TypeHuman Otc Drug
Proprietary NameCold Sore Fever Blister Treatment
Generic NameDocosanol
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2022-01-21
Marketing CategoryANDA /
Application NumberANDA208754
Labeler NameTopco Associates
Substance NameDOCOSANOL
Active Ingredient Strength100 mg/g
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 76162-900-07

1 TUBE in 1 PACKAGE (76162-900-07) > 2 g in 1 TUBE
Marketing Start Date2022-01-21
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Cold Sore Fever Blister Treatment" or generic name "Docosanol"

NDCBrand NameGeneric Name
0363-9220Cold Sore Fever Blister TreatmentDocosanol
0363-9222Cold Sore Fever Blister TreatmentDocosanol
11673-846Cold Sore Fever Blister TreatmentDocosanol
11673-926Cold Sore Fever Blister TreatmentDocosanol
11822-0951Cold Sore Fever Blister TreatmentDocosanol
11822-3927Cold Sore Fever Blister TreatmentDocosanol
11822-3951Cold Sore Fever Blister TreatmentDocosanol
11822-3977Cold Sore Fever Blister TreatmentDocosanol
11822-4763Cold Sore Fever Blister TreatmentDocosanol
21130-823Cold Sore Fever Blister TreatmentDocosanol
30142-981Cold Sore Fever Blister TreatmentDocosanol
0135-0200ABREVAdocosanol
0135-0300ABREVAdocosanol
30142-322Cold Sore Fever BlisterDocosanol
0363-2981DocosanolDocosanol
0472-2981DocosanolDocosanol
0591-2981DocosanolDocosanol
21130-422DocosanolDocosanol
21922-023DocosanolDocosanol

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.